Accepted at 3:09 p.m. Jul, 10, 2026 by Caleb_Meadows
Author: Caleb_Meadows
Related Note: 1485037189108 4
Rationale for change

Clarifies that SNRI's (particularly venlafaxine) can be used in PTSD

Source: AMBOSS - https://next.amboss.com/us/article/-80D63?utm_source=navbar&utm_medium=anki&utm_campaign=anki&utm_term=ptsd&guid=qo%252CwEGs%253F%25219&aid=12b9157f-d56c-49c3-9a37-0a1030bd0668&uid=xUOVE27u0#Z2b5a77ee2051fee6724ad813948b6748

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::07_Selective_serotonin_reuptake_inhibitors #AK_Step2_v12::#AMBOSS::NH0-qh #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#SketchyPsych::09_Trauma_Disorders::01_Stress_Disorders::01_Acute_Stress_Disorder_&_PTSD #AK_Step1_v12::#UWorld::Step::11846 #AK_Step2_v12::#Resources_by_rotation::Psych::fapsych::pharm #AK_Step2_v12::#UWorld::Step::12186 #AK_Step2_v12::#OME::04_Psychiatry::04_PTSD #AK_Step2_v12::#UWorld::COMLEX::102091 #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#Pixorize::03_Pharmacology::17_Psych_Pharm::New::10_SSRIs #AK_Step1_v12::#Pixorize::03_Pharmacology::17_Psych_Pharm::04_SSRIs #AK_Step2_v12::Original_decks::Dorian::psych::fapsych::pharm #AK_Step1_v12::#Bootcamp::Psychiatry::09_Pharmacology::01_SSRIs #AK_Step2_v12::#Bootcamp::Psychiatry::01_Diagnosis_and_Management::01_Mood_Disorders::05_SSRIs_and_SNRIs #AK_Step3_v12::#UWorld::12600 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::06_Antidepressants::*Preferred_Medications_For_Selected_Psychiatric_Conditions #AK_Step2_v12::#Resources_by_rotation::FM::ome::psych::pharm #AK_Step2_v12::#OME::04_Psychiatry::15_Psych_Pharm_2 #AK_Step1_v12::#UWorld::COMLEX::25732 #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::19_SSRIs #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::08_Serotonin-norepinephrine_reuptake_inhibitors #AK_Step2_v12::Original_decks::Dorian::fam::ome::psych::pharm #AK_Step1_v12::#OME::Clinical::Psychiatry::Mostly_Mood::Post-Traumatic_Stress_Disorders #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::02_Antidepressants_&_Anxiolytics::01_SSRIs,_SNRIs,_Cyproheptadine #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Step2_v12::#UWorld::Step::11937 #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::20_SNRIs #AK_Step2_v12::#AMBOSS::Eta82m #AK_Step2_v12::!Shelf::Psych::no_dupes #AK_Step2_v12::!Shelf::FM::no_dupes